title: Active surveillance of prostate cancer in African American men.
abstract: Active surveillance (AS) is a treatment strategy for prostate cancer (PCa) whereby patients diagnosed with PCa undergo ongoing characterization of their disease with the intent of avoiding radical treatment. Previously, AS has been demonstrated to be a reasonable option for men with low-risk PCa, but existing cohorts largely consist of Caucasian Americans. Because African Americans have a greater incidence, more aggressive, and potentially more lethal PCa than Caucasian Americans, it is unclear if AS is appropriate for African Americans. We performed a review of the available literature on AS with a focus on African Americans.
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA. Electronic address: jsilbers@tulane.edu.
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Silberstein
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Allison H
authors.initials: AH
authors.lastname: Feibus
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Michael M
authors.initials: MM
authors.lastname: Maddox
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Asim B
authors.initials: AB
authors.lastname: Abdel-Mageed
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Krishnarao
authors.initials: K
authors.lastname: Moparty
authors.affiliation: Department of Urology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Raju
authors.initials: R
authors.lastname: Thomas
authors.affiliation: Department of Medical Oncology, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
mesh_terms: D001741:Black or African American / Q000706:statistics & numerical data*; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000208:ethnology* / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D057832:Watchful Waiting / Q000379:methods* / Q000706:statistics & numerical data
chemical_list: D017430:Prostate-Specific Antigen